Skip to Content

Cladribine

In the US, Cladribine (cladribine systemic) is a member of the drug class antimetabolites and is used to treat Hairy Cell Leukemia and Multiple Sclerosis.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BB04

CAS registry number (Chemical Abstracts Service)

0004291-63-8

Chemical Formula

C10-H12-Cl-N5-O3

Molecular Weight

285

Therapeutic Category

Cytostatic agent: Antimetabolite

Chemical Name

2-Chloro-2'-deoxyadenosine

Foreign Names

  • Cladribinum (Latin)
  • Cladribin (German)
  • Cladribine (French)
  • Cladribina (Spanish)

Generic Names

  • Cladribine (OS: BAN, DCF, USAN, JAN)
  • CdA (IS)
  • Chlorodeoxyadenosine (IS)
  • RWJ 26251 (IS)
  • RWJ 26251-000 (IS)
  • Cladribine (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Cladribinum (PH: Ph. Eur. 8)

Brand Names

  • Ai Bo Ding
    Hisun Pfizer, China
  • Biodribin
    Inst. Biotechn. i Antybiotykow, Poland
  • Cladribine Agila
    Agila, Netherlands; Agila Specialties, Poland
  • Cladribine Bedford
    Bedford, United States
  • Hemobine
    Dosa, Argentina
  • Intocel
    Sidus, Argentina
  • Leustat
    Janssen Cilag, Argentina; Janssen-Cilag, Egypt; Janssen-Cilag, United Kingdom; Janssen-Cilag, Lebanon
  • Leustatin
    Cilag, Hong Kong; Janssen, Australia; Janssen, Brazil; Janssen, Finland; Janssen, Lebanon; Janssen, Norway; Janssen, New Zealand; Janssen, Taiwan; Janssen, South Africa; Janssen Cilag, Netherlands; Janssen Pharmaceutical, Japan; Janssen-Cilag, Belgium; Janssen-Cilag, Switzerland; Janssen-Cilag, Germany; Janssen-Cilag, Greece; Janssen-Cilag, Italy; Janssen-Cilag, Portugal
  • Leustatine
    Janssen-Cilag, France
  • Litak
    Inter Farmacia Italia, Italy; Key Oncologics, South Africa; Lipomed, Austria; Lipomed, Belgium; Lipomed, Switzerland; Lipomed, Czech Republic; Lipomed, Germany; Lipomed, Denmark; Lipomed, Spain; Lipomed, France; Lipomed, United Kingdom; Lipomed, Hungary; Lipomed, Israel; Lipomed, Lithuania; Lipomed, Netherlands; Lipomed, Norway; Lipomed, Poland; Lipomed, Portugal; Lipomed, Romania; Lipomed, Serbia; Lipomed, Taiwan; Lipomed GmbH, Greece; Medifront, Finland; Medis Adria, Croatia (Hrvatska); Orphan, Australia
  • Movectro
    Merck Serono, Australia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide